Exparel and Education to Avoid Opioids After Carpal Tunnel Release
ConditionCarpal Tunnel Syndrome
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorKettering Health Network
About this trial
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.
Eligibility criteria
Qualifiers
carpal tunnel syndrome diagnosed either by physical exam or EMG
age >18.
Disqualifiers
allergy to bupivacaine
pre-operative opioid usage within the last six months
patients allergic to Percocet or acetaminophen
patients taking tricyclic antidepressants (interaction with bupivacaine)
Trial design
Treatments tested in this trial
- Differing pain management strategy
Treatment groups
64 Participants
are divided into 2 treatment groupsSponsors and collaborators
Kettering Health Network
Lead sponsor
American Society for Surgery of the Hand
Collaborator
Source ClinicalTrials.gov